Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Sachsen, Germany
Martin Stöter, Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany
Martin Stöter joined in 2006 the High-throughput Technology Development Studio (TDS) at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG, Dresden, Germany) as a research scientist, where he was responsible for running large RNAi and chemical screening campaigns. Over the past years assay development, automated microscopy, image and data analysis of high-content screening projects have become his key expertise. Before, he has worked at the Leibniz Institute of Virology and the University of Ulm (both Germany). By training he is a biochemist (Ruhr University Bochum, Germany).
Disclosure information not submitted.
Sunday, February 4, 2024
8:30 AM – 4:30 PM EST